Cargando…

Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study

Objective To investigate any long term effects on mortality in participants in experimental research related to chemical warfare agents from 1941 to 1989. Design Historical cohort study. Data sources Archive of UK government research facility at Porton Down, UK military personnel records, and nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Venables, K M, Brooks, C, Linsell, L, Keegan, T J, Langdon, T, Fletcher, T, Nieuwenhuijsen, M J, Maconochie, N E S, Doyle, P, Beral, V, Carpenter, L M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269894/
https://www.ncbi.nlm.nih.gov/pubmed/19318699
http://dx.doi.org/10.1136/bmj.b613
_version_ 1782222520453169152
author Venables, K M
Brooks, C
Linsell, L
Keegan, T J
Langdon, T
Fletcher, T
Nieuwenhuijsen, M J
Maconochie, N E S
Doyle, P
Beral, V
Carpenter, L M
author_facet Venables, K M
Brooks, C
Linsell, L
Keegan, T J
Langdon, T
Fletcher, T
Nieuwenhuijsen, M J
Maconochie, N E S
Doyle, P
Beral, V
Carpenter, L M
author_sort Venables, K M
collection PubMed
description Objective To investigate any long term effects on mortality in participants in experimental research related to chemical warfare agents from 1941 to 1989. Design Historical cohort study. Data sources Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants 18 276 male members of the UK armed forces who had spent one or more short periods (median 4 days between first and last test) at Porton Down and a comparison group of 17 600 non-Porton Down veterans followed to 31 December 2004. Main outcome measures Mortality rate ratio of Porton Down compared with non-Porton Down veterans and standardised mortality ratio of each veteran group compared with the general population. Both ratios adjusted for age group and calendar period. Results Porton Down veterans were similar to non-Porton Down veterans in year of enlistment (median 1951) but had longer military service (median 6.2 v 5.0 years). After a median follow-up of 43 years, 40% (7306) of Porton Down and 39% (6900) of non-Porton Down veterans had died. All cause mortality was slightly greater in Porton Down veterans (rate ratio 1.06, 95% confidence interval 1.03 to 1.10, P<0.001), more so for deaths outside the UK (1.26, 1.09 to 1.46). Of 12 cause specific groups examined, rate ratios in Porton Down veterans were increased for deaths attributed to infectious and parasitic (1.57, 1.07 to 2.29), genitourinary (1.46, 1.04 to 2.04), circulatory (1.07, 1.01 to 1.12), and external (non-medical) (1.17, 1.00 to 1.37) causes and decreased for deaths attributed to in situ, benign, and unspecified neoplasms (0.60, 0.37 to 0.99). There was no clear relation between type of chemical exposure and cause specific mortality. The mortality in both groups of veterans was lower than that in the general population (standardised mortality ratio 0.88, 0.85 to 0.90; 0.82, 0.80 to 0.84). Conclusions Mortality was slightly higher in Porton Down than non-Porton Down veterans. With lack of information on other important factors, such as smoking or service overseas, it is not possible to attribute the small excess mortality to chemical exposures at Porton Down.
format Online
Article
Text
id pubmed-3269894
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-32698942012-02-09 Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study Venables, K M Brooks, C Linsell, L Keegan, T J Langdon, T Fletcher, T Nieuwenhuijsen, M J Maconochie, N E S Doyle, P Beral, V Carpenter, L M BMJ Research Objective To investigate any long term effects on mortality in participants in experimental research related to chemical warfare agents from 1941 to 1989. Design Historical cohort study. Data sources Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants 18 276 male members of the UK armed forces who had spent one or more short periods (median 4 days between first and last test) at Porton Down and a comparison group of 17 600 non-Porton Down veterans followed to 31 December 2004. Main outcome measures Mortality rate ratio of Porton Down compared with non-Porton Down veterans and standardised mortality ratio of each veteran group compared with the general population. Both ratios adjusted for age group and calendar period. Results Porton Down veterans were similar to non-Porton Down veterans in year of enlistment (median 1951) but had longer military service (median 6.2 v 5.0 years). After a median follow-up of 43 years, 40% (7306) of Porton Down and 39% (6900) of non-Porton Down veterans had died. All cause mortality was slightly greater in Porton Down veterans (rate ratio 1.06, 95% confidence interval 1.03 to 1.10, P<0.001), more so for deaths outside the UK (1.26, 1.09 to 1.46). Of 12 cause specific groups examined, rate ratios in Porton Down veterans were increased for deaths attributed to infectious and parasitic (1.57, 1.07 to 2.29), genitourinary (1.46, 1.04 to 2.04), circulatory (1.07, 1.01 to 1.12), and external (non-medical) (1.17, 1.00 to 1.37) causes and decreased for deaths attributed to in situ, benign, and unspecified neoplasms (0.60, 0.37 to 0.99). There was no clear relation between type of chemical exposure and cause specific mortality. The mortality in both groups of veterans was lower than that in the general population (standardised mortality ratio 0.88, 0.85 to 0.90; 0.82, 0.80 to 0.84). Conclusions Mortality was slightly higher in Porton Down than non-Porton Down veterans. With lack of information on other important factors, such as smoking or service overseas, it is not possible to attribute the small excess mortality to chemical exposures at Porton Down. BMJ Publishing Group Ltd. 2009-03-24 /pmc/articles/PMC3269894/ /pubmed/19318699 http://dx.doi.org/10.1136/bmj.b613 Text en © Venables et al 2009 http://creativecommons.org/licenses/by-nc/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Venables, K M
Brooks, C
Linsell, L
Keegan, T J
Langdon, T
Fletcher, T
Nieuwenhuijsen, M J
Maconochie, N E S
Doyle, P
Beral, V
Carpenter, L M
Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study
title Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study
title_full Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study
title_fullStr Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study
title_full_unstemmed Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study
title_short Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study
title_sort mortality in british military participants in human experimental research into chemical warfare agents at porton down: cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269894/
https://www.ncbi.nlm.nih.gov/pubmed/19318699
http://dx.doi.org/10.1136/bmj.b613
work_keys_str_mv AT venableskm mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT brooksc mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT linselll mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT keegantj mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT langdont mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT fletchert mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT nieuwenhuijsenmj mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT maconochienes mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT doylep mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT beralv mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy
AT carpenterlm mortalityinbritishmilitaryparticipantsinhumanexperimentalresearchintochemicalwarfareagentsatportondowncohortstudy